Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease

[1]  K. Lu,et al.  Insulin Resistance in Patients with Chronic Kidney Disease , 2012, Journal of biomedicine & biotechnology.

[2]  W. Mitch,et al.  Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  P. Li,et al.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[4]  W. Mitch,et al.  Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. , 2010, Journal of the American Society of Nephrology : JASN.

[5]  V. Raia,et al.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. , 2010, The Journal of clinical investigation.

[6]  W. Mitch,et al.  Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. , 2009, The Journal of clinical investigation.

[7]  W. Mitch,et al.  IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. , 2009, Journal of the American Society of Nephrology : JASN.

[8]  B. C. Kwan,et al.  Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[9]  Yu Chen,et al.  Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding. , 2007, American journal of physiology. Endocrinology and metabolism.

[10]  W. Mitch,et al.  Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. , 2006, Journal of the American Society of Nephrology : JASN.

[11]  Jie Du,et al.  Dual Pathways for Nuclear Factor &kgr;B Activation by Angiotensin II in Vascular Smooth Muscle: Phosphorylation of p65 by I&kgr;B Kinase and Ribosomal Kinase , 2005, Circulation research.

[12]  S. Ishiura,et al.  Denervation enhances the expression of SHPS-1 in rat skeletal muscle. , 2005, Journal of biochemistry.

[13]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[14]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[15]  W. Frontera,et al.  IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.

[16]  W. Mitch,et al.  Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. , 2004, Journal of the American Society of Nephrology : JASN.

[17]  C. Kahn,et al.  Mouse models of insulin resistance. , 2002, Physiological reviews.

[18]  W. Mitch,et al.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. , 2004, The Journal of clinical investigation.

[19]  W. Frontera,et al.  IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.

[20]  Z. Bloomgarden,et al.  Inflammation and insulin resistance. , 2003, Diabetes care.

[21]  L. Maile,et al.  Regulation of Insulin-like Growth Factor I Receptor Dephosphorylation by SHPS-1 and the Tyrosine Phosphatase SHP-2* , 2002, The Journal of Biological Chemistry.

[22]  W. Mitch,et al.  Glucocorticoids Induce Proteasome C3 Subunit Expression in L6 Muscle Cells by Opposing the Suppression of Its Transcription by NF-κB* , 2000, The Journal of Biological Chemistry.

[23]  G. Pacini,et al.  Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. , 1998, Kidney international.

[24]  H. Gin,et al.  A low-protein diet improves insulin sensitivity of endogenous glucose production in predialytic uremic patients. , 1997, The American journal of clinical nutrition.

[25]  F Giorgino,et al.  Specific Increase in p85α Expression in Response to Dexamethasone Is Associated with Inhibition of Insulin-like Growth Factor-I Stimulated Phosphatidylinositol 3-Kinase Activity in Cultured Muscle Cells* , 1997, The Journal of Biological Chemistry.

[26]  A. Ullrich,et al.  A family of proteins that inhibit signalling through tyrosine kinase receptors , 1997, Nature.

[27]  T. Miyazaki,et al.  Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. , 1997, Mineral and electrolyte metabolism.

[28]  M. Kasuga,et al.  A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion , 1996, Molecular and cellular biology.

[29]  W. Mitch,et al.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. , 1996, The Journal of clinical investigation.

[30]  V. Jorgetti,et al.  The role of experimental chronic renal failure and aluminium intoxication in cellular immune response. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  J. Vadgama,et al.  Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. , 1996, The Journal of clinical investigation.

[32]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[33]  M. Papa,et al.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. , 1993, The Journal of biological chemistry.

[34]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[35]  J. Friedman,et al.  Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. , 1991, The American journal of physiology.

[36]  M. Sinha,et al.  Insulin resistance in uremia: insulin receptor kinase activity in liver and muscle from chronic uremic rats. , 1988, The American journal of physiology.

[37]  W. Mitch,et al.  Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. , 1987, The Journal of clinical investigation.

[38]  R. DeFronzo,et al.  Insulin resistance in uremia mediated by postbinding defects. , 1982, Kidney international.

[39]  R. DeFronzo,et al.  Insulin resistance in uremia. , 1981, The Journal of clinical investigation.